Posaconazole formulations not interchangeable

Tablet and oral suspension formulations of the antifungal posaconazole (Noxafil) are not interchangeable, warns the MHRA in its latest Drug Safety Update

Further information
View Noxafil drug record
Summary of Product Characteristics
MHRA Drug Safety Update

Prescribers should specify the dosage form on each prescription to avoid confusion.

Switching from oral solution to tablets, or vice versa, can result in over- or under-dosing and the risk of dose-related toxicity or lack of efficacy.

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.